Bio-Techne Corp (NASDAQ: TECH) is 4.39% higher on its value in year-to-date trading and has touched a low of $61.16 and a high of $85.57 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TECH stock was last observed hovering at around $74.77 in the last trading session, with the day’s gains setting it 0.42%.
Currently trading at $75.19, the stock is 1.64% and 1.90% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.47 million and changing 0.56% at the moment leaves the stock 1.66% off its SMA200. TECH registered 3.13% gain for a year compared to 6-month gain of 4.33%. The firm has a 50-day simple moving average (SMA 50) of $73.7916 and a 200-day simple moving average (SMA200) of $73.961.
The stock witnessed a 0.91% loss in the last 1 month and extending the period to 3 months gives it a 1.97%, and is 4.39% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.30% over the week and 3.00% over the month.
Bio-Techne Corp (TECH) has around 3100 employees, a market worth around $11.95B and $1.17B in sales. Current P/E ratio is 80.13 and Fwd P/E is 34.48. Profit margin for the company is 12.86%. Distance from 52-week low is 22.94% and -12.13% from its 52-week high. The company has generated returns on investments over the last 12 months (5.97%).
The EPS is expected to grow by 6.04% this year
829.0 institutions hold shares in Bio-Techne Corp (TECH), with institutional investors hold 100.55% of the company’s shares. The shares outstanding are 158.88M, and float is at 157.23M with Short Float at 2.23%. Institutions hold 99.50% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 18.18 million shares valued at $1.3 billion. The investor’s holdings represent 11.5581 of the TECH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.99 million shares valued at $1.07 billion to account for 9.5277 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 8.53 million shares representing 5.4198 and valued at over $610.87 million, while STATE STREET CORP holds 4.0054 of the shares totaling 6.3 million with a market value of $451.46 million.
Bio-Techne Corp (TECH) Insider Activity
The most recent transaction is an insider sale by BAUMGARTNER ROBERT V, the company’s Director. SEC filings show that BAUMGARTNER ROBERT V sold 16,000 shares of the company’s common stock on Aug 08 ’24 at a price of $72.10 per share for a total of $1.15 million. Following the sale, the insider now owns 43401.0 shares.
Still, SEC filings show that on May 14 ’24, HIGGINS JOHN L (Director) disposed off 4,000 shares at an average price of $83.84 for $0.34 million. The insider now directly holds 36,608 shares of Bio-Techne Corp (TECH).
